Acute Porphyria Drug Database

N07AA51 - Neostigmine, Combinations
Propably not porphyrinogenic
PNP

Rationale
Neostigmine: Probably not interfering with hepatic CYPs. References consider it safe. Glycopyrrone: Not metabolised. References consider it safe
Chemical description
(To be edited, initial data ST OCT 04) A combination of an anticholinergic and a cholinesterase inhibitor used for reversal of non-depolarisation neuromuscular blockade Neostigmine: Cholinesterase inhibitor of short duration. No data pointing to CYP-interaction. Glucopyrrone: Quarternary ammonium compound with anticholinergic properties. Ionized at physiological pH. Rapidly excreted in unchanged form in urine. Neostigmine: MFM James, RJ Hift. Porphyrias. Br J Anaesth 2000; 85, 143-53: use EPI-list: safe South African list: use Glycopyrrone: MFM James, RJ Hift. Porphyrias. Br J Anaesth 2000; 85, 143-53: use EPI-list: safe

Similar drugs
Explore alternative drugs in similar therapeutic classes N07A / N07AA or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙